Airway Epithelial Cell Differentiation via Sequential Inhibitor Culture
Find Innovative SolutionsGenerate Solutions
Solution Overview
Problem
There is a lack of methods for inducing airway epithelial cells from human pluripotent stem cells, which are essential for understanding airway diseases and developing therapeutic agents, particularly for ciliary motility disorders and mucociliary clearance abnormalities.
Innovation Solution
A method involving a series of culture steps using specific growth factors and inhibitors, including activin A, GSK3β inhibitors, BMP inhibitors, retinoic acid, FGF10, and ROCK inhibitors, to differentiate pluripotent stem cells into proximal airway epithelial cells, which can then be further differentiated into ciliated, mucin-producing, basal, and Club cells through three-dimensional culture.
Engineering Contradictions & Design Principles
Engineering Contradiction Analysis
1Adaptability or versatility
If pluripotent stem cells are cultured with various growth factors and inhibitors to induce differentiation into airway epithelial cells, then the ability to produce specific airway cell types is improved, but the complexity of the culture system increases
Solution Approach 1:
The differentiation process is divided into multiple sequential culture steps, each with specific growth factors and inhibitors. Step 1 uses activin A and GSK3β inhibitor to form ventral anterior foregut cells. Step 2 adds BMP and TGFβ inhibitors to generate airway epithelial progenitor cells. Step 3 introduces BMP4 and retinoic acid for proximal airway epithelial progenitor cells. Step 4 uses FGF10 and ROCK inhibitor for final airway epithelial cell differentiation. This segmentation allows complex differentiation to be managed through controlled sequential addition of factors.
Solution Approach 2:
The method performs preliminary actions by first establishing ventral anterior foregut cells from pluripotent stem cells before proceeding to airway-specific differentiation. This preliminary step creates a committed progenitor population that is more responsive to subsequent airway-specific growth factors, thereby simplifying the overall differentiation protocol.
2Manufacturing precision
If a multi-step culture method is used to differentiate pluripotent stem cells into airway epithelial cells, then the manufacturing precision of specific cell types is improved, but the time required for production increases
Solution Approach 1:
The differentiation protocol maintains continuous useful action by using overlapping culture conditions. GSK3β inhibitor is present from Step 1 through Step 3, and ROCK inhibitor is introduced in Step 3 and continued in Step 4. This continuity maintains cell proliferation and prevents differentiation arrest, allowing the process to proceed efficiently through each stage without loss of cell viability or proliferation capacity.
Solution Approach 2:
The method systematically changes chemical parameters at each step: Step 1 uses activin A (100 ng/mL) and GSK3β inhibitor (3 μM). Step 2 adds BMP inhibitor (100 ng/mL) and TGFβ inhibitor (10 μM). Step 3 introduces BMP4 (20 ng/mL) and retinoic acid (100 nM). Step 4 adds FGF10 (100 ng/mL). These parameter changes drive progressive differentiation while maintaining efficient cell production.
Data Source
Figure 1
Figure 2A~2B
Figure 2C~2D
AI summary
This invention provides a method for stably producing airway epithelial cells from pluripotent stem cells. Specifically, the invention relates to a method for producing airway epithelial cells from pluripotent stem cells comprising steps: (1) culturing pluripotent stem cells in a medium containing activin A and a GSK3β inhibitor; (2) culturing the cells obtained in Step (1) in a medium containing a BMP inhibitor and a TGFβ inhibitor; (3) culturing the cells obtained in Step (2) in a medium containing BMP4, retinoic acid, and a GSK3β inhibitor; (5) subjecting the cells obtained after Step (3) to three-dimensional culture in a medium containing a GSK3β inhibitor, FGF10, and a ROCK inhibitor; and (6) subjecting the proximal airway epithelial progenitor cells obtained in Step (5) to three-dimensional culture in a medium containing a ROCK inhibitor.